1. Use of Gentamicin for Sepsis and Septic Shock in Anaesthesia-Intensive Care Unit: A Clinical Practice Evaluation
- Author
-
Patrick Gerome, Andrei Cividjian, Antoine Lamblin, Cyril Pernod, and Wey Pierre-François
- Subjects
Creatinine ,Septic shock ,business.industry ,peak plasma concentration (Cmax) ,Intensive Care ,Cmax ,Context (language use) ,gentamicin ,Corrective formula ,medicine.disease ,intensive care unit ,Intensive care unit ,law.invention ,sepsis ,Sepsis ,chemistry.chemical_compound ,chemistry ,law ,Anesthesia ,medicine ,Original Article ,Gentamicin ,Medical prescription ,business ,medicine.drug - Abstract
Objective Numerous cases of gentamicin underdosing have been described in the literature in the context of sepsis and septic shock in anaesthesia-intensive care units (ICU). A survey of clinical practice was conducted with the aim to rationalise the use of gentamicin in the unit. The secondary objective was to propose a corrective formula for adjusting individual dosage. Methods A single-centre survey was used to determine the initial dose of gentamicin administered, in an anaesthesia-ICU, during the first hours of sepsis/septic shock. An initial retrospective phase allowed focusing on the points of improvement in terms of prescription. A second prospective phase enabled the evaluation of benefits following the implemented changes. Results Fifty-one patients were included during the retrospective phase (2014–2015) and 28 patients during the prospective phase (2016–2017). Out-of-guideline prescriptions significantly decreased between these two study periods (i.e., pulmonary infections decreased from 70.5% to 18%, p
- Published
- 2020
- Full Text
- View/download PDF